EXERCISE TRAIL
EXERCISE TRAIL
批准号:
8461399
负责人:
Laura D. Baker
金额:
$164.47万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Activities of Daily LivingAdherenceAdultAerobic ExerciseAffectAgingAlzheimer&aposs DiseaseAmyloid beta-ProteinAnimalsAnteriorAreaBiological MarkersBoxingBrainBrain regionBrain-Derived Neurotrophic FactorCardiovascular DiseasesCerebrospinal FluidClinicalClinical dementia rating scaleCognitionCognitiveCommunitiesDataDementiaDiabetes MellitusDiseaseElderlyEmotionalEnrollmentEnsureEpisodic memoryExerciseGoalsGrowth FactorHealthHealth educationHeart RateHippocampus (Brain)Home environmentHumanImpaired cognitionIndependent LivingInflammationInterventionIntervention StudiesLiteratureMagnetic Resonance ImagingMeasuresMedialMedicalMethodsModelingMoodsNeuronsObservational StudyParietalParticipantPathologyPerformancePhysical activityPilot ProjectsProcessQuestionnairesRandomized Controlled TrialsReportingRestSample SizeSecureShort-Term MemorySiteSleepStagingStretchingStructureSumSupervisionSupport SystemTNFSF10 geneTestingTherapeuticTherapeutic EffectTimeVascular Endothelial Growth FactorsVentricularVulnerable PopulationsWorkarmbasebrain volumecerebral atrophycognitive functioncooperative studyeffective interventioneffective therapyexecutive functionfitnessflexibilityfunctional outcomesfunctional statusgeriatric depressionimprovedinnovationmeetingsmild cognitive impairmentmouse modelnormal agingpeerphysical conditioningpreventprogramsresponsesedentarystandard of caretau Proteinstau phosphorylationtreatment as usualtreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project 2 of the ADCS U01 renewal application will be a pivotal multi-site randomized controlled trial to assess whether supervised aerobic exercise is an effective therapeutic option to ameliorate cognitive decline, slow brain atrophy, and favorably alter Alzheimer pathology in older adults with mild cognitive impairment (MCI) and thus in the earliest stages of disease. Two short-term intervention studies completed . thus far provide preliminary support for a cognition-enhancing effect of exercise in MCI. The proposed trial will examine the effects of a structured and supervised 12-month moderate- to high-intensity aerobic exercise intervention versus stretching on cognition and biomarkers of AD pathology in cerebrospinal fluid (CSF) and brain structure using MRI. Sedentary older adults (60-85 yrs old) with amnestic MCI (n=300, CDR=0.5) will be enrolled. Both arms of the intervention will be carried out in community exercise facilities, and physical activity will be gradually increased over the first few weeks and then maintained at the targeted duration and heart rate intensity for the rest of the 12-month trial. Participants will benefit from close supervision using established methods from other successful multi-site exercise trials, on-going health education, and a diversified support system provided by staff, fitness trainers, and an exercise 'Buddy' for peer support. Each week, the interventionist will meet with the participant at the exercise facility to supervise the activity routine, review study goals and progress, identify and resolve issues related to continued adherence, provide encouragement and emotional support, and develop the exercise plan for the coming week. Cognitive and functional outcomes, collected at baseline, months 6 and 12, and again following a 6-month unsupervised extension of the intervention, will include the ADAS-Cog13, supplemented with other tests of executive function, a global (composite) measure of executive function and of episodic memory, the Clinical Dementia Rating scale (sum of boxes). Activities of Independent Living for MCI, and the Geriatric Depression Scale. In addition, participants will complete a brief cognitive test and questionnaire about mood and sleep each week during the supervised exercise session. Biomarkers of exercise efficacy, collected at baseline and month 12, will include measures of aging and AD pathology in CSF, and whole and regional brain volumes. Although regular exercise is widely accepted and recommended to maintain optimum physical health and prevent various medical conditions such as cardiovascular disease and diabetes, exercise is not prescribed with the same conviction to maintain optimum cognitive health or prevent diseases associated with cognitive decline. The results of this study will provide critical data regarding the efficacy of aerobic exercise to improve cognition and favorably alter markers of Alzheimer's disease pathology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REC Core
-
批准号:10461188
-
项目类别:
-
资助金额:$10.79万
-
财政年份:2021
-
负责人:Laura D. Baker
-
依托单位:
Outreach Core
-
批准号:10262852
-
项目类别:
-
资助金额:$30.44万
-
财政年份:2021
-
负责人:Laura D. Baker
-
依托单位:
REC Core
-
批准号:10663253
-
项目类别:
-
资助金额:$10.79万
-
财政年份:2021
-
负责人:Laura D. Baker
-
依托单位:
Outreach Core
-
批准号:10663242
-
项目类别:
-
资助金额:$30.44万
-
财政年份:2021
-
负责人:Laura D. Baker
-
依托单位:
REC Core
-
批准号:10262854
-
项目类别:
-
资助金额:$10.79万
-
财政年份:2021
-
负责人:Laura D. Baker
-
依托单位:
Outreach Core
-
批准号:10461186
-
项目类别:
-
资助金额:$30.44万
-
财政年份:2021
-
负责人:Laura D. Baker
-
依托单位:
POINTER-zzz: Sleep Ancillary to U.S. Study to Protect Brain Health through Lifestyle Intervention to Reduce Risk of Alzheimer's Disease
-
批准号:10645111
-
项目类别:
-
资助金额:$58.22万
-
财政年份:2019
-
负责人:Laura D. Baker
-
依托单位:
POINTER-zzz: Sleep Ancillary to U.S. Study to Protect Brain Health through Lifestyle Intervention to Reduce Risk of Alzheimer's Disease - Admin
-
批准号:10429446
-
项目类别:
-
资助金额:$33.76万
-
财政年份:2019
-
负责人:Laura D. Baker
-
依托单位:
POINTER-zzz: Sleep Ancillary to U.S. Study to Protect Brain Health through Lifestyle Intervention to Reduce Risk of Alzheimer's Disease
-
批准号:10176336
-
项目类别:
-
资助金额:$109.45万
-
财政年份:2019
-
负责人:Laura D. Baker
-
依托单位:
POINTER-zzz: Sleep Ancillary to U.S. Study to Protect Brain Health through Lifestyle Intervention to Reduce Risk of Alzheimer's Disease
-
批准号:10434040
-
项目类别:
-
资助金额:$113.02万
-
财政年份:2019
-
负责人:Laura D. Baker
-
依托单位:
POINTER-zzz: Sleep Ancillary to U.S. Study to Protect Brain Health through Lifestyle Intervention to Reduce Risk of Alzheimer's Disease
-
批准号:9811102
-
项目类别:
-
资助金额:$137.07万
-
财政年份:2019
-
负责人:Laura D. Baker
-
依托单位:
Women's Health Initiative Sleep Hypoxia Effects on Resilience (WHISPER)
-
批准号:9309405
-
项目类别:
-
资助金额:$218.36万
-
财政年份:2017
-
负责人:Laura D. Baker
-
依托单位:
Cocoa Supplement and Multivitamin Outcomes Study in the Mind (COSMOS-Mind)
-
批准号:9103266
-
项目类别:
-
资助金额:$80.65万
-
财政年份:2016
-
负责人:Laura D. Baker
-
依托单位:
EXERCISE TRAIL
-
批准号:8982202
-
项目类别:
-
资助金额:$69.77万
-
财政年份:--
-
负责人:Laura D. Baker
-
依托单位:
Core E: Outreach and Recruitment Core
-
批准号:9753087
-
项目类别:
-
资助金额:$14.72万
-
财政年份:--
-
负责人:Laura D. Baker
-
依托单位:
Core E: Outreach and Recruitment Core
-
批准号:9172412
-
项目类别:
-
资助金额:$14.46万
-
财政年份:--
-
负责人:Laura D. Baker
-
依托单位:
Core E: Outreach and Recruitment Core
-
批准号:9981589
-
项目类别:
-
资助金额:$22.51万
-
财政年份:--
-
负责人:Laura D. Baker
-
依托单位:
EXERCISE TRAIL
-
批准号:8601654
-
项目类别:
-
资助金额:$240.86万
-
财政年份:--
-
负责人:Laura D. Baker
-
依托单位:
Core F: Research Education Component (RL5)
-
批准号:9981591
-
项目类别:
-
资助金额:$4.81万
-
财政年份:--
-
负责人:Laura D. Baker
-
依托单位:
Core F: Research Education Component (RL5)
-
批准号:9753090
-
项目类别:
-
资助金额:$5.05万
-
财政年份:--
-
负责人:Laura D. Baker
-
依托单位:
海外基金